Research compound
Ipamorelin
A ghrelin-receptor agonist investigated for hormonal and gastrointestinal effects.
THE RESEARCH QUESTION
What is being investigated?
A randomised trial studied postoperative bowel recovery, a specific hospital setting. Wellness marketing often focuses instead on growth-hormone signalling.
EVIDENCE SNAPSHOT
Human trials for specific questions
A surgical study is not proof of better sleep, muscle growth or anti-ageing benefits in healthy users.
LIMITS & SAFETY
What should you know?
Safety concerns and route-specific evidence gaps remain.
FOLLOW THE EVIDENCE
Sources & further reading
- Ipamorelin: randomised postoperative ileus study (2014) ↗Human trial
- FDA: safety information for bulk substances used in compounding ↗Regulator
Checked 8 October 2026. Sources may describe different populations, formulations and jurisdictions. This overview is not a systematic review or individual medical advice.
PUT THE EVIDENCE IN CONTEXT
Questions about what you’ve read?
Request an educational conversation with Matthew about the evidence and questions to raise with your medical professional.